Status:

COMPLETED

Impact of PH Values of the Embryo Culture Medium on Success of in Vitro Fertilization (IVF)

Lead Sponsor:

University Hospital, Toulouse

Conditions:

Embryo Growth Disorder

Humans

Eligibility:

FEMALE

18-40 years

Phase:

NA

Brief Summary

The objective of this study is to compare, through a multicentric randomized trial, the impact of two pH values in the embryo culture medium on the clinical results of In Vitro Fertilization (IVF) pro...

Detailed Description

Despite progress in Assisted Reproductive Technology (ART), the livebirth rate per oocyte retrieval during In Vitro Fertilization (IVF) remain relatively low (15 à 25%). This is in part due to the sen...

Eligibility Criteria

Inclusion

  • Couples whose woman is 18 to 40 years old and man is 18 to 60 at the time of inclusion.
  • Infertile couple with a medical indication of IVF-ICSI according to criteria applied in each center.
  • First or second ICSI attempt with fresh embryo transfer.
  • Signature of informed consent by both partners of the couple
  • Affiliation to a social security scheme or equivalent for both partners of the couple.
  • Fitting the inclusion criteria for IVF according the the French law.

Exclusion

  • Use of spermatozoa extracted by testicular biopsy.
  • Freeze-al strategy (without fresh embryo transfer) decided before embryo culture
  • Absence of mature oocyte (metaphase II) at the day of the puncture
  • Uterine pathology affecting implantation (uterine malformation, diffuse adenomyosis ...)
  • One of the two partners (or both) is (are) infected with HIV, HCV or HBV in the year before the inclusion
  • One of the two partners (or both) is (are) in safeguarding justice, under guardianship or trusteeship.
  • Couple having already participated once in the study.
  • Couple enrolled in another interventional clinical study

Key Trial Info

Start Date :

October 14 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 19 2024

Estimated Enrollment :

429 Patients enrolled

Trial Details

Trial ID

NCT04456478

Start Date

October 14 2020

End Date

June 19 2024

Last Update

January 13 2025

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

CHU de BORDEAUX

Bordeaux, France

2

Centre AMP BIOPYRENEES

Pau, France

3

CHU de TOULOUSE

Toulouse, France